L-Arginine infusion increases glucose clearance during prolonged exercise in humans

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 1, 2006, Pages

  McConell, G K ^a,b   Huynh, N N ^b   Lee Young, R S ^a   Canny, B J ^b   Wadley, G D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Contraction; Glucose kinetics; Nitric oxide

Indexed keywords

ARGININE; FATTY ACID; GLUCOSE; GLYCEROL; INSULIN; LACTIC ACID; NITRIC OXIDE; CARBON DIOXIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXERCISE; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HEART RATE; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LUNG GAS EXCHANGE; MALE; MUSCLE METABOLISM; NORMAL HUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; EXERCISE TEST; INTRAVENOUS DRUG ADMINISTRATION; METABOLIC CLEARANCE RATE; METABOLISM; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TIME;

ADULT; ARGININE; BLOOD GLUCOSE; CARBON DIOXIDE; DOUBLE-BLIND METHOD; EXERCISE; EXERCISE TEST; EXERTION; FATTY ACIDS, NONESTERIFIED; GLUCOSE; GLYCEROL; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; METABOLIC CLEARANCE RATE; NITRIC OXIDE; OXYGEN CONSUMPTION; PULMONARY GAS EXCHANGE; TIME FACTORS;

EID: 33644874488     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00263.2005     Document Type: Article

References (64)

1. Abel T, Knechtle B, Perret C, Eser P, von Arx P, and Knecht H. Influence of chronic supplementation of arginine aspartate in endurance athletes on performance and substrate metabolism - a randomized, double-blind, placebo-controlled study. Int J Sports Med 26: 344-349, 2005.
2. Andersson K, Gaudiot N, Ribiere C, Elizalde M, Giudicelli Y, and Arner P. A nitric oxide-mediated mechanism regulates lipolysis in human adipose tissue in vivo. Br J Pharmacol 126: 1639-1645, 1999.
3. Balon TW and Nadler JL. Evidence that nitric oxide increases glucose transport in skeletal muscle. J Appl Physiol 82: 359-363, 1997.
4. Balon TW and Nadler JL. Nitric oxide release is present from incubated skeletal muscle preparations. J Appl Physiol 77: 2519-2521, 1994.
5. Bode-Boger SM, Boger RH, Galland A, Tsikas D, and Frolich JC. L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship. Br J Clin Pharmacol 46: 489-497, 1998.
6. Bode-Boger SM, Boger RH, Loffler M, Tsikas D, Brabant G, and Frolich JC. L-arginine stimulates NO-dependent vasodilation in healthy humans - effect of somatostatin pretreatment. J Investig Med 47: 43-50, 1999.
7. Bode-Böger SM, Böger RH, Schroder EP, and Frolich JC. Exercise increases systemic nitric oxide production in men. J Cardiovasc Risk 1: 173-178, 1994.
8. Borg GAV. Perceived exertion: a note on "history" and methods. Med Sci Sports Exerc 5: 90-93, 1973.
9. Bradley SJ, Kingwell BA, and McConell GK. Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans. Diabetes 48: 1815-1821, 1999.
10. Bratusch-Marrain P, Bjorkman O, Hagenfeldt L, Waldhausl W, and Wahren J. Influence of arginine on splanchnic glucose metabolism in man. Diabetes 28: 126-131, 1979.
11. Brett SE, Cockcroft JR, Mant TG, Ritter JM, and Chowienczyk PJ. Haemodynamic effects of inhibition of nitric oxide synthase and of L-arginine at rest and during exercise. J Hypertens 16: 429-435, 1998.
12. Ceremuzynski L, Chamiec T, and Herbaczynska-Cedro K. Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol 80: 331-333, 1997.
13. Cheng JW and Baldwin SN. L-arginine in the management of cardiovascular diseases. Ann Pharmacother 35: 755-764, 2001.
14. Chernick S. Determination of Glycerol in Acyl Glycerols. New York: Academic, 1969.
15. Colombani PC, Bitzi R, Frey-Rindova P, Frey W, Arnold M, Langhans W, and Wenk C. Chronic arginine aspartate supplementation in runners reduces total plasma amino acid level at rest and during a marathon run. Eur J Nutr 38: 263-270, 1999.
16. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, and Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30: 1000-1007, 1981.
17. Etgen GJ Jr, Fryburg DA, and Gibbs EM. Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes 46: 1915-1919, 1997.
18. Frandsen U, Bangsbo J, Sander M, Hoffner L, Betak A, Saltin B, and Hellsten Y. Exercise-induced hyperaemia and leg oxygen uptake are not altered during effective inhibition of nitric oxide synthase with N(G)-nitro-L-arginine methyl ester in humans. J Physiol 531: 257-264, 2001.
19. Frandsen U, Hoffner L, Betak A, Saltin B, Bangsbo J, and Hellsten Y. Endurance training does not alter the level of neuronal nitric oxide synthase in human skeletal muscle. J Appl Physiol 89: 1033-1038, 2000.
20. Frandsen U, Lopez-Figueroa M, and Hellsten Y. Localization of nitric oxide synthase in human skeletal muscle. Biochem Biophys Res Commun 227: 88-93, 1996.
21. Gaudiot N, Jaubert AM, Charbonnier E, Sabourault D, Lacasa D, Giudicelli Y, and Ribiere C. Modulation of white adipose tissue lipolysis by nitric oxide. J Biol Chem 273: 13475-13481, 1998.
22. Hargreaves M, Kiens B, and Richter EA. Effect of increased plasma free fatty acid concentrations on muscle metabolism in exercising men. J Appl Physiol 70: 194-201, 1991.
23. Hayashi T, Wojtaszewski JF, and Goodyear LJ. Exercise regulation of glucose transport in skeletal muscle. Am J Physiol Endocrinol Metab 273: E1039-E1051, 1997.
24. Hespel P, Vergauwen L, Vandenberghe K, and Richter EA. Significance of insulin for glucose metabolism in skeletal muscle during contractions. Diabetes 45, Suppl 1: S99-S104, 1996.
25. Hickner RC, Fisher JS, Ehsani AA, and Kohrt WM. Role of nitric oxide in skeletal muscle blood flow at rest and during dynamic exercise in humans. Am J Physiol Heart Circ Physiol 273: H405-H410, 1997.
26. Higaki Y, Hirshman MF, Fujii N, and Goodyear LJ. Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes 50: 241-247, 2001.
27. Hishikawa K, Nakaki T, Tsuda M, Esumi H, Ohshima H, Suzuki H, Saruta T, and Kato R. Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man. Jpn Heart J 33: 41-48, 1992.
28. Jenkins AB, Chisholm DJ, James DE, Ho KY, and Kraegen EW. Exercise-induced hepatic glucose output is precisely sensitive to the rate of systemic glucose supply. Metabolism 34: 431-436, 1985.
29. Jeukendrup A, Saris WH, Brouns F, and Kester AD. A new validated endurance performance test. Med Sci Sports Exerc 28: 266-270, 1996.
30. Jeukendrup AE, Raben A, Gijsen A, Stegen JH, Brouns F, Saris WH, and Wagenmakers AJ. Glucose kinetics during prolonged exercise in highly trained human subjects: effect of glucose ingestion. J Physiol 515: 579-589, 1999.
31. Jordan J, Tank J, Stoffels M, Franke G, Christensen NJ, Luft FC, and Boschmann M. Interaction between beta-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism. J Clin Endocrinol Metab 86: 2803-2810, 2001.
32. Kanaya Y, Nakamura M, Kobayashi N, and Hiramori K. Effects of L-arginine on lower limb vasodilator reserve and exercise capacity in patients with chronic heart failure. Heart 81: 512-517, 1999.
33. Kennedy JW, Hirshman MF, Gervino EV, Ocel JV, Forse RA, Hoenig SJ, Aronson D, Goodyear LJ, and Horton ES. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes 48: 1192-1197, 1999.
34. Kingwell B, Formosa M, Muhlmann M, Bradley S, and McConell G. Nitric oxide synthase inhibition reduces glucose uptake during exercise in individuals with type 2 diabetes more than in control subjects. Diabetes 51: 2572-2580, 2002.
35. Klatt P, Cacho J, Crespo MD, Herrera E, and Ramos P. Nitric oxide inhibits isoproterenol-stimulated adipocyte lipolysis through oxidative inactivation of the beta-agonist. Biochem J 351: 485-493, 2000.
36. Lee AD, Hansen PA, and Holloszy JO. Wortmannin inhibits insulin-stimulated but not contraction-stimulated glucose transport activity in skeletal muscle. FEBS Lett 361: 51-54, 1995.
37. Lund S, Holman GD, Schmitz O, and Pedersen O. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci USA 92: 5817-5821, 1995.
38. Maxwell AJ, Ho HV, Le CQ, Lin PS, Bernstein D, and Cooke JP. L-arginine enhances aerobic exercise capacity in association with augmented nitric oxide production. J Appl Physiol 90: 933-938, 2001.
39. McConell G, Fabris S, Proietto J, and Hargreaves M. Effect of carbohydrate ingestion on glucose kinetics during exercise. J Appl Physiol 77: 1537-1541, 1994.
40. McConell G, Kloot K, and Hargreaves M. Effect of timing of carbohydrate ingestion on endurance exercise performance. Med Sci Sports Exerc 28: 1300-1304, 1996.
41. McConell G, Snow RJ, Proietto J, and Hargreaves M. Muscle metabolism during prolonged exercise in humans: influence of carbohydrate availability. J Appl Physiol 87: 1083-1086, 1999.
42. Ming Z, Han C, and Lautt WW. Nitric oxide inhibits norepinephrine-induced hepatic vascular responses but potentiates hepatic glucose output. Can J Physiol Pharmacol 78: 36-44, 2000.
43. Odland LM, Heigenhauser GJ, Wong D, Hollidge-Horvat MG, and Spriet LL. Effects of increased fat availability on fat-carbohydrate interaction during prolonged exercise in men. Am J Physiol Regul Integr Comp Physiol 274: R894-R902, 1998.
44. Piatti PM, Monti LD, Valsecchi G, Magni F, Setola E, Marchesi F, Galli-Kienle M, Pozza G, and Alberti KG. Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care 24: 875-880, 2001.
45. Quyyumi AA. Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine. J Am Coll Cardiol 32: 904-911, 1998.
46. Rådegran G and Saltin B. Nitric oxide in the regulation of vasomotor tone in human skeletal muscle. Am J Physiol Heart Circ Physiol 276: H1951-H1960, 1999.
47. Radziuk J, Norwich KH, and Vranic M. Experimental validation of measurements of glucose turnover in nonsteady state. Am J Physiol Endocrinol Metab Gastrointest Physiol 234: E84-E93, 1978.
48. Rector TS, Bank AJ, Mullen KA, Tschumperlin LK, Sih R, Pillai K, and Kubo SH. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 93: 2135-2141, 1996.
49. Richter EA, Derave W, and Wojtaszewski JF. Glucose, exercise and insulin: emerging concepts. J Physiol 535: 313-322, 2001.
50. Roberts CK, Barnard RJ, Jasman A, and Balon TW. Acute exercise increases nitric oxide synthase activity in skeletal muscle. Am J Physiol Endocrinol Metab 277: E390-E394, 1999.
51. Roberts CK, Barnard RJ, Scheck SH, and Balon TW. Exercise-stimulated glucose transport in skeletal muscle is nitric oxide dependent. Am J Physiol Endocrinol Metab 273: E220-E225, 1997.
52. Romijn JA, Coyle EF, Sidossis LS, Zhang XJ, and Wolfe RR. Relationship between fatty acid delivery and fatty acid oxidation during strenuous exercise. J Appl Physiol 79: 1939-1945, 1995.
53. Rottman J, Bracy D, Malabanan C, Yue Z, Clanton J, and Wasserman D. Contrasting effects of exercise and NOS inhibition on tissue-specific fatty acid and glucose uptake in mice. Am J Physiol Endocrinol Metab 283: E116-E123, 2002.
54. Rudnick J, Puttmann B, Tesch PA, Alkner B, Schoser BG, Salanova M, Kirsch K, Gunga HC, Schiffl G, Luck G, and Blottner D. Differential expression of nitric oxide synthases (NOS 1-3) in human skeletal muscle following exercise countermeasure during 12 weeks of bed rest. FASEB J 18: 1228-1230, 2004.
55. Silveira LR, Pereira-Da-Silva L, Juel C, and Hellsten Y. Formation of hydrogen peroxide and nitric oxide in rat skeletal muscle cells during contractions. Free Radic Biol Med 35: 455-464, 2003.
56. Steele R, Wall JS, DeBodo RC, and Altszuler N. Measurement of the size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187: 15-24, 1956.
57. Stephens TJ, Canny BJ, Snow RJ, and McConell GK. 5′-Aminoimidazole-4-carboxamide-ribonucleoside-activated glucose transport is not prevented by nitric oxide synthase inhibition in rat isolated skeletal muscle. Clin Exp Pharmacol Physiol 31: 419-423, 2004.
58. Van Loon LJC, Thomason-Hughes M, Constantin-Teodosiu D, Koopman R, Greenhaff PL, Hardie DG, Keizer HA, Saris WHM, and Wagenmakers AJM. Inhibition of adipose tissue lipolysis increases intramuscular lipid and glycogen use in vivo in humans. Am J Physiol Endocrinol Metab 289: E482-E493, 2005.
59. Vincent MA, Barrett EJ, Lindner JR, Clark MG, and Rattigan S. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab 285: E123-E129, 2003.
60. Walker HA, McGing E, Fisher I, Boger RH, Bode-Boger SM, Jackson G, Ritter JM, and Chowienczyk PJ. Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance. J Am Coll Cardiol 38: 499-505, 2001.
61. Wennmalm A, Edlund A, Granstrom EF, and Wiklund O. Acute supplementation with the nitric oxide precursor L-arginine does not improve cardiovascular performance in patients with hypercholesterolemia. Atherosclerosis 118: 223-231, 1995.
62. Wheatley CM, Rattigan S, Richards SM, Barrett EJ, and Clark MG. Skeletal muscle contraction stimulates capillary recruitment and glucose uptake in insulin-resistant obese Zucker rats. Am J Physiol Endocrinol Metab 287: E804-E809, 2004.
63. Young ME and Leighton B. Evidence for altered sensitivity of the nitric oxide/cGMP signalling cascade in insulin-resistant skeletal muscle. Biochem J 329: 73-79, 1998.
64. Zderic TW, Davidson CJ, Schenk S, Byerley LO, and Coyle EF. High-fat diet elevates resting intramuscular triglyceride concentration and whole body lipolysis during exercise. Am J Physiol Endocrinol Metab 286: E217-E225, 2004.